|4th January 2021||Philip H Coelho||13,513||Grant/award etc.||$1.48||$19,999.24|
|22nd December 2020||Patrick J Mcenany||7,507||Payment by withholding||$0.00|
|22nd December 2020||Charles B O'Keeffe||1,333||Exercise of derivative||$0.00|
|22nd December 2020||Patrick J Mcenany||30,833||Exercise of derivative||$0.00|
|22nd December 2020||Steve Miller||20,000||Exercise of derivative||$0.00|
|22nd December 2020||Philip H Coelho||1,333||Exercise of derivative||$0.00|
|22nd December 2020||Gary Ingenito||3,668||Open or private sale||$3.45||$12,643.60|
|22nd December 2020||Gary Ingenito||14,666||Exercise of derivative||$0.00|
|22nd December 2020||Richard J Daly||1,333||Exercise of derivative||$0.00|
|22nd December 2020||David S Tierney||1,333||Exercise of derivative||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Catalyst Pharmaceuticals is a biopharmaceutical company. The company was founded Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL. It is developing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases.